vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Kentucky First Federal Bancorp (KFFB). Click either name above to swap in a different company.

Kentucky First Federal Bancorp is the larger business by last-quarter revenue ($2.8M vs $1.8M, roughly 1.6× INVO Fertility, Inc.). Kentucky First Federal Bancorp runs the higher net margin — 10.7% vs -150.5%, a 161.2% gap on every dollar of revenue. On growth, Kentucky First Federal Bancorp posted the faster year-over-year revenue change (28.3% vs 22.6%). Kentucky First Federal Bancorp produced more free cash flow last quarter ($-367.0K vs $-1.8M). Over the past eight quarters, Kentucky First Federal Bancorp's revenue compounded faster (24.0% CAGR vs 12.8%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Kentucky First Federal Bancorp is a U.S. regional bank holding company based in Kentucky. It offers retail and commercial banking services including deposits, mortgage loans, consumer lending and small business financing, serving local individual customers and small-to-medium enterprises across its Kentucky operating regions.

IVF vs KFFB — Head-to-Head

Bigger by revenue
KFFB
KFFB
1.6× larger
KFFB
$2.8M
$1.8M
IVF
Growing faster (revenue YoY)
KFFB
KFFB
+5.7% gap
KFFB
28.3%
22.6%
IVF
Higher net margin
KFFB
KFFB
161.2% more per $
KFFB
10.7%
-150.5%
IVF
More free cash flow
KFFB
KFFB
$1.4M more FCF
KFFB
$-367.0K
$-1.8M
IVF
Faster 2-yr revenue CAGR
KFFB
KFFB
Annualised
KFFB
24.0%
12.8%
IVF

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
IVF
IVF
KFFB
KFFB
Revenue
$1.8M
$2.8M
Net Profit
$-2.6M
$304.0K
Gross Margin
Operating Margin
-93.1%
14.1%
Net Margin
-150.5%
10.7%
Revenue YoY
22.6%
28.3%
Net Profit YoY
-62.2%
2238.5%
EPS (diluted)
$-0.77
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
KFFB
KFFB
Q4 25
$2.8M
Q3 25
$1.8M
$2.7M
Q2 25
$1.9M
$2.4M
Q1 25
$1.6M
$2.2M
Q4 24
$1.7M
$2.2M
Q3 24
$1.4M
$2.0M
Q2 24
$1.8M
$2.0M
Q1 24
$1.6M
$1.8M
Net Profit
IVF
IVF
KFFB
KFFB
Q4 25
$304.0K
Q3 25
$-2.6M
$344.0K
Q2 25
$-5.3M
$176.0K
Q1 25
$-17.4M
$7.0K
Q4 24
$-3.6M
$13.0K
Q3 24
$-1.6M
$-15.0K
Q2 24
$-2.2M
$-1.1M
Q1 24
$-1.6M
$-107.0K
Gross Margin
IVF
IVF
KFFB
KFFB
Q4 25
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
IVF
IVF
KFFB
KFFB
Q4 25
14.1%
Q3 25
-93.1%
17.0%
Q2 25
-160.4%
10.3%
Q1 25
-1042.1%
0.7%
Q4 24
-202.0%
0.3%
Q3 24
-90.7%
-1.0%
Q2 24
-100.9%
-58.7%
Q1 24
-95.7%
-7.9%
Net Margin
IVF
IVF
KFFB
KFFB
Q4 25
10.7%
Q3 25
-150.5%
12.9%
Q2 25
-283.6%
7.6%
Q1 25
-1060.1%
0.3%
Q4 24
-211.3%
0.6%
Q3 24
-113.8%
-0.7%
Q2 24
-122.2%
-56.7%
Q1 24
-101.3%
-5.8%
EPS (diluted)
IVF
IVF
KFFB
KFFB
Q4 25
$0.04
Q3 25
$-0.77
$0.04
Q2 25
$-13.30
$0.02
Q1 25
$-12.53
$0.00
Q4 24
$14.86
$0.00
Q3 24
$-15.11
$0.00
Q2 24
$-22.39
$-0.13
Q1 24
$-7.55
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
KFFB
KFFB
Cash + ST InvestmentsLiquidity on hand
$19.7M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$49.1M
Total Assets
$18.8M
$375.3M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
KFFB
KFFB
Q4 25
$19.7M
Q3 25
$14.6M
Q2 25
$19.5M
Q1 25
$27.8M
Q4 24
$21.0M
Q3 24
$17.3M
Q2 24
$18.3M
Q1 24
$15.4M
Total Debt
IVF
IVF
KFFB
KFFB
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IVF
IVF
KFFB
KFFB
Q4 25
$49.1M
Q3 25
$5.8M
$48.8M
Q2 25
$2.6M
$48.4M
Q1 25
$3.3M
$48.2M
Q4 24
$12.7M
$48.1M
Q3 24
$-23.3K
$48.2M
Q2 24
$1.4M
$48.0M
Q1 24
$10.2K
$49.0M
Total Assets
IVF
IVF
KFFB
KFFB
Q4 25
$375.3M
Q3 25
$18.8M
$366.5M
Q2 25
$19.3M
$371.2M
Q1 25
$31.7M
$380.7M
Q4 24
$46.4M
$374.2M
Q3 24
$17.0M
$375.6M
Q2 24
$17.8M
$375.0M
Q1 24
$17.3M
$369.1M
Debt / Equity
IVF
IVF
KFFB
KFFB
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
KFFB
KFFB
Operating Cash FlowLast quarter
$-1.8M
$-303.0K
Free Cash FlowOCF − Capex
$-1.8M
$-367.0K
FCF MarginFCF / Revenue
-101.6%
-12.9%
Capex IntensityCapex / Revenue
0.5%
2.3%
Cash ConversionOCF / Net Profit
-1.00×
TTM Free Cash FlowTrailing 4 quarters
$-7.8M
$-377.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
KFFB
KFFB
Q4 25
$-303.0K
Q3 25
$-1.8M
$450.0K
Q2 25
$-1.7M
$-86.0K
Q1 25
$-3.5M
$-155.0K
Q4 24
$-617.4K
$1.4M
Q3 24
$-640.8K
$-1.4M
Q2 24
$-1.5M
$-1.5M
Q1 24
$-260.6K
$-176.0K
Free Cash Flow
IVF
IVF
KFFB
KFFB
Q4 25
$-367.0K
Q3 25
$-1.8M
$445.0K
Q2 25
$-1.7M
$-235.0K
Q1 25
$-3.6M
$-220.0K
Q4 24
$-696.3K
$1.4M
Q3 24
$-1.4M
Q2 24
$-1.5M
$-1.5M
Q1 24
$-310.3K
$-191.0K
FCF Margin
IVF
IVF
KFFB
KFFB
Q4 25
-12.9%
Q3 25
-101.6%
16.7%
Q2 25
-92.6%
-9.7%
Q1 25
-216.9%
-9.9%
Q4 24
-40.6%
61.8%
Q3 24
-70.2%
Q2 24
-82.3%
-77.7%
Q1 24
-19.7%
-10.4%
Capex Intensity
IVF
IVF
KFFB
KFFB
Q4 25
2.3%
Q3 25
0.5%
0.2%
Q2 25
0.5%
6.2%
Q1 25
0.9%
2.9%
Q4 24
4.6%
3.7%
Q3 24
0.0%
0.1%
Q2 24
3.0%
3.4%
Q1 24
3.2%
0.8%
Cash Conversion
IVF
IVF
KFFB
KFFB
Q4 25
-1.00×
Q3 25
1.31×
Q2 25
-0.49×
Q1 25
-22.14×
Q4 24
111.31×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons